Company profile CERS

Cerus Corp.
Description of the company is not available.
Quarter analysis & expected interest

There is not enough data for Cerus Corporation, INTERCEPT Blood System, Platelet and plasma blood safety, Red blood cell blood safety, Cryoprecipitation blood safety, Cerus Corporation stock, Cerus Corporation financials, Cerus Corporation news, Cerus Corporation careers, Medical device blood safety to provide analysis

Correlation between past revenue and Cerus Corporation, INTERCEPT Blood System, Platelet and plasma blood safety, Red blood cell blood safety, Cryoprecipitation blood safety, Cerus Corporation stock, Cerus Corporation financials, Cerus Corporation news, Cerus Corporation careers, Medical device blood safety search interest

There is not enough data for Cerus Corporation, INTERCEPT Blood System, Platelet and plasma blood safety, Red blood cell blood safety, Cryoprecipitation blood safety, Cerus Corporation stock, Cerus Corporation financials, Cerus Corporation news, Cerus Corporation careers, Medical device blood safety to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Cerus Corporation, INTERCEPT Blood System, Platelet and plasma blood safety, Red blood cell blood safety, Cryoprecipitation blood safety, Cerus Corporation stock, Cerus Corporation financials, Cerus Corporation news, Cerus Corporation careers, Medical device blood safety to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CERS
Company name: Cerus Corp.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-01T18:43:05Z

Analyst Upgrades
This Caterpillar Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

2026-05-01T11:42:56Z

Analyst Upgrades
BTIG Upgrades Cerus to Buy, Announces $4 Price Target

2026-04-30T20:01:00Z

BusinessWire
Cerus Corporation Announces First Quarter 2026 Financial Results

2026-04-27T12:00:00Z

BusinessWire
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

2026-04-16T20:01:00Z

BusinessWire
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

2026-03-16T20:05:00Z

BusinessWire
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

2026-03-02T21:01:00Z

BusinessWire
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

2026-02-20T13:30:00Z

BusinessWire
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

2026-02-17T21:01:00Z

BusinessWire
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

2025-12-10T21:15:00Z

BusinessWire
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

2025-11-06T21:01:00Z

BusinessWire
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

2025-10-21T12:30:00Z

BusinessWire
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

2025-10-16T20:00:00Z

BusinessWire
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

2025-08-25T15:25:00-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - CERUS CORP (0001020214) (Issuer)

2025-08-25T13:00:00Z

BusinessWire
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions